Argus Research Upgrades Humana to Buy, Announces $550 Price Target
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst David Toung has upgraded Humana (NYSE:HUM) from Hold to Buy and set a price target of $550 for the company's stock.

December 12, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Humana has been upgraded by Argus Research from Hold to Buy with a new price target of $550, indicating a positive outlook on the stock.
Upgrades by analysts, especially from Hold to Buy, typically signal a bullish perspective on the stock and can lead to increased investor confidence and a potential rise in stock price. The new price target of $550 suggests a significant upside from the current trading level, which may attract investors looking for growth opportunities.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100